FDG PET Imaging of Extremities in Rheumatoid Arthritis

Area of Science:

• Nuclear Medicine
• Rheumatology
• Medical Imaging

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints.
• Assessing joint inflammation and treatment response in RA is crucial for effective management.
• Standard clinical and laboratory evaluations may not fully capture disease activity or extent.

Purpose of the Study:

• To evaluate the utility of fluorodeoxyglucose positron emission tomography (FDG PET) imaging.
• To assess the degree of joint inflammation in rheumatoid arthritis patients.
• To determine the response to therapy using standard PET parameters.

Main Methods:

• Prospective study of five newly diagnosed RA patients.
• Baseline and post-treatment FDG PET scans of hands and feet.
• Qualitative and semi-quantitative assessment of FDG uptake (SUV) correlated with clinical (DAS) and laboratory (ESR) parameters.

Main Results:

• FDG PET revealed increased uptake in RA-affected joints, correlating with clinical evaluation.
• Imaging identified subclinical joint involvement and provided disease distribution patterns.
• Post-treatment, significant correlations were found between DAS and Maximum Metabolic Disease Burden (MDB max) (RS=0.9, p=0.04), and ESR and MDB max (RS=0.9, p=0.04).
• Baseline correlations between PET parameters and DAS/ESR were not significant due to small sample size.

Conclusions:

• FDG PET imaging offers a noninvasive, quantitative method for assessing RA disease status.
• It serves as a valuable adjunct to clinical evaluation in managing rheumatoid arthritis.
• FDG PET can effectively monitor treatment response in RA patients.